Hongbing Lu

Prof. Hongbing Lu

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2018 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
BLBaojuan Li
Baojuan Li
KFKarl Friston Friston
Karl Friston Friston
MMMaria Mody
Maria Mody
HWHua‐Ning Wang
Hua‐Ning Wang
HLHongbing Lu
Hongbing Lu
DHDewen Hu
Dewen Hu

15 February 2017 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
XZXi Zhang
Xi Zhang
XXXiaopan Xu
Xiaopan Xu
QTQiang Tian
Qiang Tian
BLBaojuan Li
Baojuan Li
YWYuxia Wu
Yuxia Wu
HLHongbing Lu
Hongbing Lu

2 February 2018 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
XZXi Zhang
Xi Zhang
QTQiang Tian
Qiang Tian
LWLiang Wang
Liang Wang
YLYang Liu
Yang Liu
BLBaojuan Li
Baojuan Li
HLHongbing Lu
Hongbing Lu

25 September 2018 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
XXXiaopan Xu
Xiaopan Xu
XZXi Zhang
Xi Zhang
QTQiang Tian
Qiang Tian
HWHuanjun Wang
Huanjun Wang
LCLong‐Biao Cui
Long‐Biao Cui
YLYang Liu
Yang Liu

29 June 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
XXXiaopan Xu
Xiaopan Xu
LYL. Yin
L. Yin
XZX. Zhang
X. Zhang
Lihong LiLihong Li
Lihong Li
HLHongbing Lu
Hongbing Lu
BACKGROUND AND PURPOSE: The heterogeneity of glioblastoma contributes to the poor and variant prognosis. The aim of this retrospective study was to assess the glioblastoma heterogeneity with MR imaging textures and to evaluate its impact on survival time. MATERIALS AND METHODS: A total of 133 patients with primary glioblastoma who underwent postcontrast T1-weighted imaging (acquired before treatment) and whose data were filed with the survival times were selected from the Cancer Genome Atlas. On the basis of overall survival, the patients were divided into 2 groups: long-term (≥12 months, n = 67) and short-term (<12 months, n = 66) survival. To measure heterogeneity, we extracted 3 types of textures, co-occurrence matrix, run-length matrix, and histogram, reflecting local, regional, and global spatial variations, respectively. Then the support vector machine classification was used to determine how different texture types perform in differentiating the 2 groups, both alone and in combination. Finally, a recursive feature-elimination method was used to find an optimal feature subset with the best differentiation performance. RESULTS: When used alone, the co-occurrence matrix performed best, while all the features combined obtained the best survival stratification. According to feature selection and ranking, 43 top-ranked features were selected as the optimal subset. Among them, the top 10 features included 7 run-length matrix and 3 co-occurrence matrix features, in which all 6 regional run-length matrix features emphasizing high gray-levels ranked in the top 7. CONCLUSIONS: The results suggest that local and regional heterogeneity may play an important role in the survival stratification of patients with glioblastoma.

8 November 2018 in Medical Physics
Verified
Journal Article
Closed access
PDF file
JDJose Dolz
Jose Dolz
XXXiaopan Xu
Xiaopan Xu
JRJérôme Rony
Jérôme Rony
JYJing Yuan
Jing Yuan
YLYang Liu
Yang Liu
HLHongbing Lu
Hongbing Lu